BIOQuébec, BioNJ, and Choose New Jersey have announced the signing of a new memorandum of understanding (MOU) aimed at strengthening cooperation between the life sciences sectors in Quebec and New Jersey. The agreement was signed during Choose New Jersey's economic mission to Canada, led by the state's governor. This strategic partnership will create opportunities for members of both organizations to access new resources, connect with international markets, and participate in events designed to stimulate innovation and growth in biopharmaceutical and biotechnology industries.
"The New Jersey is the home of innovation, with an expanding life sciences sector thanks to collaboration with industrial partners abroad," said Governor Murphy. "The partnership between BIOQuébec and BioNJ is a step forward to achieve crucial outcomes aimed at advancing research and development, education, and overall growth while advocating for patients' interests in New Jersey and beyond."
The MOU provides a framework for cooperation that includes sharing best practices, promoting bilateral events such as trade missions, and participating in joint conferences. This collaboration will allow the life sciences communities of both regions to expand their reach and impact globally.
This partnership signifies a significant commitment from both organizations to advance their respective sectors while creating tangible opportunities for their members. Additional details on specific events and opportunities arising from this partnership will be communicated to members in the coming months.
Benoit Larose, President-Director General of BIOQuébec, stated: "We are thrilled to partner with BioNJ through this memorandum of understanding. In today's global context where the life sciences industry faces unprecedented challenges and opportunities, it is crucial for trade associations like ours to cultivate strong relationships with international partners. Such collaborations not only mitigate risks related to volatile supply chains but also create opportunities to generate value for our members. This partnership will enrich the biotech sectors of Quebec and New Jersey through knowledge sharing and joint initiatives, representing a concrete step towards expanding our industries' influence abroad."
"Throughout Quebec, the United States, particularly here in New Jersey, many companies have forged durable strategic partnerships," commented Debbie Hart, President & CEO of BioNJ. "Alliances like that between BioNJ and BIOQuébec serve as catalysts for innovation by sparking new ventures and fostering cutting-edge research collaborations. We look forward to uniting our members in a common mission aimed at elevating the life sciences sector with the ultimate goal of accelerating transformative medical breakthroughs for patients worldwide."
"As New Jersey's leading business attraction organization, Choose New Jersey is proud to facilitate this powerful collaboration uniting the life sciences sectors of New Jersey and Quebec to strengthen both economies," said Wesley Mathews, President & CEO of Choose New Jersey. "This agreement creates pathways for biopharmaceuticals and biotech companies in New Jersey not only to grow their operations but also disseminate their ideas globally."
About BIOQuébec
BIOQuébec is a non-profit association fully funded by its members. It represents over 220 companies and organizations active in Quebec's life sciences industry—particularly in biopharmaceuticals and biotechnology fields. BIOQuébec acts as the industry's voice by promoting networking opportunities, economic development while serving as a bridge between private sector stakeholders.
For more information visit www.bioquebec.com or follow us on LinkedIn.
About BioNJ
BioNJ is New Jersey’s life sciences trade association representing 400 research-based life science organizations across the health ecosystem—from large biopharmaceutical companies to start-ups—for over 30 years. Because Patients Can’t Wait®, BioNJ commits itself ensuring dynamic ecosystems where Science thrives Businesses grow Medicines develop Patients access lifesaving drugs.
Recognized as respected thought leader influential advocate sought-after convener within life sciences industry; works directly legislative leaders advancing medical innovation ensuring health equity healthcare accessibility drives breakthrough discoveries helps Members help Patients providing transformative resources including government industry leadership capital state incentives timely educational programs skilled talent value-driven purchasing program.
Inspired privileged working those committed improving lives Patients families worldwide visit www.BioNJ.org
For more information:
Benoit Larose
President-Director General
BIOQuébec
blarose@bioquebec.com
514-217-1167
Randi Bromberg
Senior Vice President Communications & Marketing
BioNJ
RBromberg@BioNJ.org
609-890-3158
Journalists seeking further details on Choose New Jersey’s economic mission can contact Mahen Gunaratna (mahen.gunaratna@nj.gov) Ingrid Austin (iaustin@choosenj.com) or visit choosenj.com/CanadaMission.
